首页> 外文期刊>Current opinion in pulmonary medicine >Chronic lung sepsis: lung abscess, bronchiectasis, and empyema.
【24h】

Chronic lung sepsis: lung abscess, bronchiectasis, and empyema.

机译:慢性肺败血症:肺脓肿,支气管扩张和脓胸。

获取原文
获取原文并翻译 | 示例
       

摘要

Chronic lung infections including lung abscess, bronchiectasis, and empyema remain serious medical diseases despite the availability of antimicrobial agents. Recent publications contribute to our understanding of disease pathogenesis and management of these entities. The microbial pathogen of lung abscess may be different comparing immunocompetent with immunocompromised patients, supporting a concept for aggressive diagnostic investigations and targeting of specific potential pathogens. The use of surgery in bronchiectasis may be declining, but surgical intervention remains an important strategy with favorable outcomes, especially in cases of focal bronchiectasis. For empyema, maintaining a high index of clinical suspicion may allow for diagnostic thoracentesis in patients with pleural effusions and allow initiation of appropriate tube thoracotomy drainage and use of fibrinolytics. With appropriate management, morbidity and mortality may be limited and outcomes generally favorable.
机译:尽管有抗菌药物,但包括肺脓肿,支气管扩张和脓胸在内的慢性肺部感染仍然是严重的医学疾病。最近的出版物有助于我们对疾病发病机理和这些实体的管理的理解。与免疫功能低下的患者相比,肺脓肿的微生物病原体可能有所不同,这为积极的诊断研究和针对特定潜在病原体提供了支持。支气管扩张手术的使用可能正在下降,但是手术干预仍然是一种具有良好效果的重要策略,尤其是在局灶性支气管扩张的情况下。对于脓胸,保持较高的临床怀疑指数可以对胸腔积液患者进行诊断性胸腔穿刺术,并允许适当的开胸胸腔引流术和使用纤溶剂。如果进行适当的管理,发病率和死亡率可能会受到限制,结果总体上是有利的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号